In the year since the COVID-19 pandemic first began, scientists and clinicians have learned much more about the virus and its impact on public health and special populations. Further, COVID-19 has highlighted the significant chronic disease burden in our population and magnified the fragile nature of our traditional, disease-based care models.
COVID-19 has brought attention to the importance of targeting inflammation and immune dysregulation—clinical concerns which have long stood as cornerstones of providing personalized, anti-aging medical care. Through this lens, participants of this workshop will gain the latest updates on the current public health impact of the virus, current guidelines on treating COVID-19 patients, the risks and benefits regarding current vaccines, and the emerging risk of the COVID-19 long-hauler population.
Objectives
- Review COVID-19 epidemiological data and at-risk populations.
- Analyze current treatment guidelines for acute COVID-19 infections.
- Review lifestyle tools to improve metabolic flexibility and immunocompetency.
- Synthesize the current research on available COVID-19 vaccines including risk/benefit and side effects.
- Examine the pathophysiology, diagnosis, and potential treatments for the COVID long-hauler population.
Faculty
Schedule
James Lyons-Weiler, PhD
Andrew Pugliese, MD
Elisa Song, MD
Elisa Song, MD
Sheldon Jordan, MD
Panagis Galiatsatos, MD, MHS
Pam R. Taub, MD, FACC, FASPC
Peter A. McCullough, MD, MPH
David Brownstein, MD
Leo Galland, MD
Bruce David Levy, MD
James Lavalle, RPh, CCN
Dobri Kiprov, MD, HP (ASCP)
Ritchie Shoemaker, MD